Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[seek the light]

The Game Has Changed
.

FDA classifying inflammation as a disease has Totally Changed the game. In essence the FDA has finally recognized the truth and that truth is out of control inflammation is associated with nearly all of the auto immune indications . There has been copious research for years on the connection between inflammation and many human ailments. Many big bios and pharmas are hard at work to be in position to cash in on this development.

But no other company has yet discovered a safe efficacious drug to modulate the level of inflammation the way Anatabine does. And this will be proven with the proof of concept trials for several of these indications planned by RCPI in the near future. And that human trial proof will change the game and cause many of these big companies to come calling on RCPI for the purpose of partnering. The science is very compelling and sound and being advanced very quickly by the superb new management team. The shares are a once in a lifetime buy, in my opinion.